Global T-cell Therapy Market by Indication (Hematologic Malignancies, Solid Tumours and Other Indications), by Therapy Type (CAR T-cell Therapy, TCR-based and TIL-based), by Modality (Research and Commercialized) and Region - 2023 to 2033

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Investment Feasibility Matrix
• 3.5. Value Chain Analysis
  • 3.5.1. Profit Margin Analysis
  • 3.5.2. Service Providers
• 3.6. PESTLE and Porter's Analysis
• 3.7. Regulatory Landscape
  • 3.7.1. By Key Regions
  • 3.7.2. By Key Countries
• 3.8. Regional Parent Market Outlook

4. Global T-cell Therapy Market Analysis 2018-2022 and Forecast, 2023-2033

• 4.1. Historical Market Size Value (US$ Bn) Analysis, 2018-2022
• 4.2. Current and Future Market Size Value (US$ Bn) Projections, 2023-2033
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Indication

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Bn) Analysis By Indication , 2018-2022
• 5.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Indication , 2023-2033
  • 5.3.1. Hematologic Malignancies
    • 5.3.1.1. Lymphoma
    • 5.3.1.2. Leukemia
    • 5.3.1.3. Myeloma
  • 5.3.2. Solid Tumors
    • 5.3.2.1. Melanoma
    • 5.3.2.2. Brain & Central Nervous System
    • 5.3.2.3. Liver Cancer
    • 5.3.2.4. Other Solid Tumors
  • 5.3.3. Other Indications
• 5.4. Y-o-Y Growth Trend Analysis By Indication , 2018-2022
• 5.5. Absolute $ Opportunity Analysis By Indication , 2023-2033

6. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Therapy Type

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Bn) Analysis By Therapy Type, 2018-2022
• 6.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Therapy Type, 2023-2033
  • 6.3.1. CAR T-cell Therapy
  • 6.3.2. T Cell Receptor (TCR)-based
  • 6.3.3. Tumor Infiltrating Lymphocytes (TIL)-based
• 6.4. Y-o-Y Growth Trend Analysis By Therapy Type, 2018-2022
• 6.5. Absolute $ Opportunity Analysis By Therapy Type, 2023-2033

7. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Modality

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size Value (US$ Bn) Analysis By Modality , 2018-2022
• 7.3. Current and Future Market Size Value (US$ Bn) Analysis and Forecast By Modality , 2023-2033
  • 7.3.1. Research
  • 7.3.2. Commercialized
• 7.4. Y-o-Y Growth Trend Analysis By Modality , 2018-2022
• 7.5. Absolute $ Opportunity Analysis By Modality , 2023-2033

8. Global T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Region

• 8.1. Introduction
• 8.2. Historical Market Size Value (US$ Bn) Analysis By Region, 2018-2022
• 8.3. Current Market Size Value (US$ Bn) Analysis and Forecast By Region, 2023-2033
  • 8.3.1. North America
  • 8.3.2. Latin America
  • 8.3.3. Europe
  • 8.3.4. Asia Pacific
  • 8.3.5. MEA
• 8.4. Market Attractiveness Analysis By Region

9. North America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

• 9.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
• 9.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
  • 9.2.1. By Country
    • 9.2.1.1. U.S.
    • 9.2.1.2. Canada
  • 9.2.2. By Indication
  • 9.2.3. By Therapy Type
  • 9.2.4. By Modality
• 9.3. Market Attractiveness Analysis
  • 9.3.1. By Country
  • 9.3.2. By Indication
  • 9.3.3. By Therapy Type
  • 9.3.4. By Modality
• 9.4. Key Takeaways

10. Latin America T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

• 10.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
• 10.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
  • 10.2.1. By Country
    • 10.2.1.1. Brazil
    • 10.2.1.2. Mexico
    • 10.2.1.3. Rest of Latin America
  • 10.2.2. By Indication
  • 10.2.3. By Therapy Type
  • 10.2.4. By Modality
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Indication
  • 10.3.3. By Therapy Type
  • 10.3.4. By Modality
• 10.4. Key Takeaways

11. Europe T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

• 11.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
• 11.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
  • 11.2.1. By Country
    • 11.2.1.1. Germany
    • 11.2.1.2. Italy
    • 11.2.1.3. France
    • 11.2.1.4. U.K.
    • 11.2.1.5. Spain
    • 11.2.1.6. Russia
    • 11.2.1.7. Rest of Europe
  • 11.2.2. By Indication
  • 11.2.3. By Therapy Type
  • 11.2.4. By Modality
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Indication
  • 11.3.3. By Therapy Type
  • 11.3.4. By Modality
• 11.4. Key Takeaways

12. Asia Pacific T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

• 12.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
• 12.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
  • 12.2.1. By Country
    • 12.2.1.1. China
    • 12.2.1.2. Japan
    • 12.2.1.3. India
    • 12.2.1.4. South Korea
    • 12.2.1.5. Australia
    • 12.2.1.6. Rest of APAC
  • 12.2.2. By Indication
  • 12.2.3. By Therapy Type
  • 12.2.4. By Modality
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Indication
  • 12.3.3. By Therapy Type
  • 12.3.4. By Modality
• 12.4. Key Takeaways

13. MEA T-cell Therapy Market Analysis 2018-2022 and Forecast 2023-2033, By Country

• 13.1. Historical Market Size Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
• 13.2. Market Size Value (US$ Bn) Forecast By Market Taxonomy, 2023-2033
  • 13.2.1. By Country
    • 13.2.1.1. South Africa
    • 13.2.1.2. Saudi Arabia
    • 13.2.1.3. UAE
    • 13.2.1.4. Israel
    • 13.2.1.5. Rest of MEA
  • 13.2.2. By Indication
  • 13.2.3. By Therapy Type
  • 13.2.4. By Modality
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Indication
  • 13.3.3. By Therapy Type
  • 13.3.4. By Modality
• 13.4. Key Takeaways

14. Key Countries T-cell Therapy Market Analysis

• 14.1. U.S.
  • 14.1.1. Pricing Analysis
  • 14.1.2. Market Share Analysis, 2022
    • 14.1.2.1. By Indication
    • 14.1.2.2. By Therapy Type
    • 14.1.2.3. By Modality
• 14.2. Canada
  • 14.2.1. Pricing Analysis
  • 14.2.2. Market Share Analysis, 2022
    • 14.2.2.1. By Indication
    • 14.2.2.2. By Therapy Type
    • 14.2.2.3. By Modality
• 14.3. Brazil
  • 14.3.1. Pricing Analysis
  • 14.3.2. Market Share Analysis, 2022
    • 14.3.2.1. By Indication
    • 14.3.2.2. By Therapy Type
    • 14.3.2.3. By Modality
• 14.4. Mexico
  • 14.4.1. Pricing Analysis
  • 14.4.2. Market Share Analysis, 2022
    • 14.4.2.1. By Indication
    • 14.4.2.2. By Therapy Type
    • 14.4.2.3. By Modality
• 14.5. Germany
  • 14.5.1. Pricing Analysis
  • 14.5.2. Market Share Analysis, 2022
    • 14.5.2.1. By Indication
    • 14.5.2.2. By Therapy Type
    • 14.5.2.3. By Modality
• 14.6. Italy
  • 14.6.1. Pricing Analysis
  • 14.6.2. Market Share Analysis, 2022
    • 14.6.2.1. By Indication
    • 14.6.2.2. By Therapy Type
    • 14.6.2.3. By Modality
• 14.7. France
  • 14.7.1. Pricing Analysis
  • 14.7.2. Market Share Analysis, 2022
    • 14.7.2.1. By Indication
    • 14.7.2.2. By Therapy Type
    • 14.7.2.3. By Modality
• 14.8. U.K.
  • 14.8.1. Pricing Analysis
  • 14.8.2. Market Share Analysis, 2022
    • 14.8.2.1. By Indication
    • 14.8.2.2. By Therapy Type
    • 14.8.2.3. By Modality
• 14.9. Spain
  • 14.9.1. Pricing Analysis
  • 14.9.2. Market Share Analysis, 2022
    • 14.9.2.1. By Indication
    • 14.9.2.2. By Therapy Type
    • 14.9.2.3. By Modality
• 14.10. Russia
  • 14.10.1. Pricing Analysis
  • 14.10.2. Market Share Analysis, 2022
    • 14.10.2.1. By Indication
    • 14.10.2.2. By Therapy Type
    • 14.10.2.3. By Modality
• 14.11. China
  • 14.11.1. Pricing Analysis
  • 14.11.2. Market Share Analysis, 2022
    • 14.11.2.1. By Indication
    • 14.11.2.2. By Therapy Type
    • 14.11.2.3. By Modality
• 14.12. Japan
  • 14.12.1. Pricing Analysis
  • 14.12.2. Market Share Analysis, 2022
    • 14.12.2.1. By Indication
    • 14.12.2.2. By Therapy Type
    • 14.12.2.3. By Modality
• 14.13. India
  • 14.13.1. Pricing Analysis
  • 14.13.2. Market Share Analysis, 2022
    • 14.13.2.1. By Indication
    • 14.13.2.2. By Therapy Type
    • 14.13.2.3. By Modality
• 14.14. South Korea
  • 14.14.1. Pricing Analysis
  • 14.14.2. Market Share Analysis, 2022
    • 14.14.2.1. By Indication
    • 14.14.2.2. By Therapy Type
    • 14.14.2.3. By Modality
• 14.15. Australia
  • 14.15.1. Pricing Analysis
  • 14.15.2. Market Share Analysis, 2022
    • 14.15.2.1. By Indication
    • 14.15.2.2. By Therapy Type
    • 14.15.2.3. By Modality
• 14.16. South Africa
  • 14.16.1. Pricing Analysis
  • 14.16.2. Market Share Analysis, 2022
    • 14.16.2.1. By Indication
    • 14.16.2.2. By Therapy Type
    • 14.16.2.3. By Modality
• 14.17. Saudi Arabia
  • 14.17.1. Pricing Analysis
  • 14.17.2. Market Share Analysis, 2022
    • 14.17.2.1. By Indication
    • 14.17.2.2. By Therapy Type
    • 14.17.2.3. By Modality
• 14.18. UAE
  • 14.18.1. Pricing Analysis
  • 14.18.2. Market Share Analysis, 2022
    • 14.18.2.1. By Indication
    • 14.18.2.2. By Therapy Type
    • 14.18.2.3. By Modality
• 14.19. Israel
  • 14.19.1. Pricing Analysis
  • 14.19.2. Market Share Analysis, 2022
    • 14.19.2.1. By Indication
    • 14.19.2.2. By Therapy Type
    • 14.19.2.3. By Modality

15. Market Structure Analysis

• 15.1. Competition Dashboard
• 15.2. Competition Benchmarking
• 15.3. Market Share Analysis of Top Players
  • 15.3.1. By Regional
  • 15.3.2. By Indication
  • 15.3.3. By Therapy Type
  • 15.3.4. By Modality

16. Competition Analysis

• 16.1. Competition Deep Dive
  • 16.1.1. Novartis AG
    • 16.1.1.1. Overview
    • 16.1.1.2. Product Portfolio
    • 16.1.1.3. Profitability by Market Segments
    • 16.1.1.4. Sales Footprint
    • 16.1.1.5. Strategy Overview
      • 16.1.1.5.1. Marketing Strategy
      • 16.1.1.5.2. Product Strategy
      • 16.1.1.5.3. Channel Strategy
  • 16.1.2. Merck KGaA
    • 16.1.2.1. Overview
    • 16.1.2.2. Product Portfolio
    • 16.1.2.3. Profitability by Market Segments
    • 16.1.2.4. Sales Footprint
    • 16.1.2.5. Strategy Overview
      • 16.1.2.5.1. Marketing Strategy
      • 16.1.2.5.2. Product Strategy
      • 16.1.2.5.3. Channel Strategy
  • 16.1.3. Gilead Sciences Inc.
    • 16.1.3.1. Overview
    • 16.1.3.2. Product Portfolio
    • 16.1.3.3. Profitability by Market Segments
    • 16.1.3.4. Sales Footprint
    • 16.1.3.5. Strategy Overview
      • 16.1.3.5.1. Marketing Strategy
      • 16.1.3.5.2. Product Strategy
      • 16.1.3.5.3. Channel Strategy
  • 16.1.4. TCR2 Therapeutics Inc
    • 16.1.4.1. Overview
    • 16.1.4.2. Product Portfolio
    • 16.1.4.3. Profitability by Market Segments
    • 16.1.4.4. Sales Footprint
    • 16.1.4.5. Strategy Overview
      • 16.1.4.5.1. Marketing Strategy
      • 16.1.4.5.2. Product Strategy
      • 16.1.4.5.3. Channel Strategy
  • 16.1.5. Bluebird Bio Inc
    • 16.1.5.1. Overview
    • 16.1.5.2. Product Portfolio
    • 16.1.5.3. Profitability by Market Segments
    • 16.1.5.4. Sales Footprint
    • 16.1.5.5. Strategy Overview
      • 16.1.5.5.1. Marketing Strategy
      • 16.1.5.5.2. Product Strategy
      • 16.1.5.5.3. Channel Strategy
  • 16.1.6. Sorrento Therapeutics
    • 16.1.6.1. Overview
    • 16.1.6.2. Product Portfolio
    • 16.1.6.3. Profitability by Market Segments
    • 16.1.6.4. Sales Footprint
    • 16.1.6.5. Strategy Overview
      • 16.1.6.5.1. Marketing Strategy
      • 16.1.6.5.2. Product Strategy
      • 16.1.6.5.3. Channel Strategy
  • 16.1.7. Fate Therapeutics
    • 16.1.7.1. Overview
    • 16.1.7.2. Product Portfolio
    • 16.1.7.3. Profitability by Market Segments
    • 16.1.7.4. Sales Footprint
    • 16.1.7.5. Strategy Overview
      • 16.1.7.5.1. Marketing Strategy
      • 16.1.7.5.2. Product Strategy
      • 16.1.7.5.3. Channel Strategy
  • 16.1.8. Pfizer Inc
    • 16.1.8.1. Overview
    • 16.1.8.2. Product Portfolio
    • 16.1.8.3. Profitability by Market Segments
    • 16.1.8.4. Sales Footprint
    • 16.1.8.5. Strategy Overview
      • 16.1.8.5.1. Marketing Strategy
      • 16.1.8.5.2. Product Strategy
      • 16.1.8.5.3. Channel Strategy
  • 16.1.9. Amgen
    • 16.1.9.1. Overview
    • 16.1.9.2. Product Portfolio
    • 16.1.9.3. Profitability by Market Segments
    • 16.1.9.4. Sales Footprint
    • 16.1.9.5. Strategy Overview
      • 16.1.9.5.1. Marketing Strategy
      • 16.1.9.5.2. Product Strategy
      • 16.1.9.5.3. Channel Strategy
  • 16.1.10. Celgene Corporation
    • 16.1.10.1. Overview
    • 16.1.10.2. Product Portfolio
    • 16.1.10.3. Profitability by Market Segments
    • 16.1.10.4. Sales Footprint
    • 16.1.10.5. Strategy Overview
      • 16.1.10.5.1. Marketing Strategy
      • 16.1.10.5.2. Product Strategy
      • 16.1.10.5.3. Channel Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

List of Tables

• Table 1: Global T-cell Therapy Market Value (US$ Bn) Forecast by Region, 2018-2033
• Table 2: Global T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
• Table 3: Global T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
• Table 4: Global T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
• Table 5: North America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
• Table 6: North America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
• Table 7: North America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
• Table 8: North America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
• Table 9: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
• Table 10: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
• Table 11: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
• Table 12: Latin America T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
• Table 13: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
• Table 14: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
• Table 15: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
• Table 16: Europe T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
• Table 17: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
• Table 18: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
• Table 19: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
• Table 20: Asia Pacific T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033
• Table 21: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Country, 2018-2033
• Table 22: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Indication , 2018-2033
• Table 23: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Therapy Type, 2018-2033
• Table 24: MEA T-cell Therapy Market Value (US$ Bn) Forecast by Modality , 2018-2033

List of Figures

• Figure 1: Global T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
• Figure 2: Global T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
• Figure 3: Global T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
• Figure 4: Global T-cell Therapy Market Value (US$ Bn) by Region, 2023-2033
• Figure 5: Global T-cell Therapy Market Value (US$ Bn) Analysis by Region, 2018-2033
• Figure 6: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Region, 2023-2033
• Figure 7: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Region, 2023-2033
• Figure 8: Global T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
• Figure 9: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
• Figure 10: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
• Figure 11: Global T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
• Figure 12: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
• Figure 13: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
• Figure 14: Global T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
• Figure 15: Global T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
• Figure 16: Global T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
• Figure 17: Global T-cell Therapy Market Attractiveness by Indication , 2023-2033
• Figure 18: Global T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
• Figure 19: Global T-cell Therapy Market Attractiveness by Modality , 2023-2033
• Figure 20: Global T-cell Therapy Market Attractiveness by Region, 2023-2033
• Figure 21: North America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
• Figure 22: North America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
• Figure 23: North America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
• Figure 24: North America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
• Figure 25: North America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
• Figure 26: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
• Figure 27: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
• Figure 28: North America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
• Figure 29: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
• Figure 30: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
• Figure 31: North America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
• Figure 32: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
• Figure 33: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
• Figure 34: North America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
• Figure 35: North America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
• Figure 36: North America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
• Figure 37: North America T-cell Therapy Market Attractiveness by Indication , 2023-2033
• Figure 38: North America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
• Figure 39: North America T-cell Therapy Market Attractiveness by Modality , 2023-2033
• Figure 40: North America T-cell Therapy Market Attractiveness by Country, 2023-2033
• Figure 41: Latin America T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
• Figure 42: Latin America T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
• Figure 43: Latin America T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
• Figure 44: Latin America T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
• Figure 45: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
• Figure 46: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
• Figure 47: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
• Figure 48: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
• Figure 49: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
• Figure 50: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
• Figure 51: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
• Figure 52: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
• Figure 53: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
• Figure 54: Latin America T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
• Figure 55: Latin America T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
• Figure 56: Latin America T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
• Figure 57: Latin America T-cell Therapy Market Attractiveness by Indication , 2023-2033
• Figure 58: Latin America T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
• Figure 59: Latin America T-cell Therapy Market Attractiveness by Modality , 2023-2033
• Figure 60: Latin America T-cell Therapy Market Attractiveness by Country, 2023-2033
• Figure 61: Europe T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
• Figure 62: Europe T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
• Figure 63: Europe T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
• Figure 64: Europe T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
• Figure 65: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
• Figure 66: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
• Figure 67: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
• Figure 68: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
• Figure 69: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
• Figure 70: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
• Figure 71: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
• Figure 72: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
• Figure 73: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
• Figure 74: Europe T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
• Figure 75: Europe T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
• Figure 76: Europe T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
• Figure 77: Europe T-cell Therapy Market Attractiveness by Indication , 2023-2033
• Figure 78: Europe T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
• Figure 79: Europe T-cell Therapy Market Attractiveness by Modality , 2023-2033
• Figure 80: Europe T-cell Therapy Market Attractiveness by Country, 2023-2033
• Figure 81: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
• Figure 82: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
• Figure 83: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
• Figure 84: Asia Pacific T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
• Figure 85: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
• Figure 86: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
• Figure 87: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
• Figure 88: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
• Figure 89: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
• Figure 90: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
• Figure 91: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
• Figure 92: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
• Figure 93: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
• Figure 94: Asia Pacific T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
• Figure 95: Asia Pacific T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
• Figure 96: Asia Pacific T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
• Figure 97: Asia Pacific T-cell Therapy Market Attractiveness by Indication , 2023-2033
• Figure 98: Asia Pacific T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
• Figure 99: Asia Pacific T-cell Therapy Market Attractiveness by Modality , 2023-2033
• Figure 100: Asia Pacific T-cell Therapy Market Attractiveness by Country, 2023-2033
• Figure 101: MEA T-cell Therapy Market Value (US$ Bn) by Indication , 2023-2033
• Figure 102: MEA T-cell Therapy Market Value (US$ Bn) by Therapy Type, 2023-2033
• Figure 103: MEA T-cell Therapy Market Value (US$ Bn) by Modality , 2023-2033
• Figure 104: MEA T-cell Therapy Market Value (US$ Bn) by Country, 2023-2033
• Figure 105: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Country, 2018-2033
• Figure 106: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Country, 2023-2033
• Figure 107: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Country, 2023-2033
• Figure 108: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Indication , 2018-2033
• Figure 109: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Indication , 2023-2033
• Figure 110: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Indication , 2023-2033
• Figure 111: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Therapy Type, 2018-2033
• Figure 112: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Therapy Type, 2023-2033
• Figure 113: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Therapy Type, 2023-2033
• Figure 114: MEA T-cell Therapy Market Value (US$ Bn) Analysis by Modality , 2018-2033
• Figure 115: MEA T-cell Therapy Market Value Share (%) and BPS Analysis by Modality , 2023-2033
• Figure 116: MEA T-cell Therapy Market Y-o-Y Growth (%) Projections by Modality , 2023-2033
• Figure 117: MEA T-cell Therapy Market Attractiveness by Indication , 2023-2033
• Figure 118: MEA T-cell Therapy Market Attractiveness by Therapy Type, 2023-2033
• Figure 119: MEA T-cell Therapy Market Attractiveness by Modality , 2023-2033
• Figure 120: MEA T-cell Therapy Market Attractiveness by Country, 2023-2033